|Articles|January 1, 2016
- BioPharm International-01-01-2016
- Volume 29
- Issue 1
BioPharm International, January 2016 Issue (PDF)
Click the title above to open the BioPharm International January 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 10 years ago
Tools for Continuous Bioprocess Developmentabout 10 years ago
Framing Biopharma Success in 2016about 10 years ago
Going Small to Achieve Success on the Commercial Scaleabout 10 years ago
Politics and Pricing Will Challenge Manufacturers in 2016about 10 years ago
Serialization: Getting Past the Quick Fixabout 10 years ago
EMA Guideline on Setting Health-Based Exposure Limitsabout 10 years ago
Outsourcing Outlook for 2016about 10 years ago
Managing Market Expansion’s Effect on ProceduresNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
4
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
5
